Lord, Abbett & Co. LLC Legend Biotech Corp Transaction History

Lord, Abbett & Co. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	SELL	$57.25 - $69.74 $3.29 Million - $4.01 Million	-57,526 Reduced 94.44%	3,385 $204,000
Q3 2023 Nov 13, 2023	SELL	$63.16 - $76.5 $31.8 Million - $38.5 Million	-502,798 Reduced 89.19%	60,911 $4.09 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $23.5 Million - $38.1 Million	507,281 Added 898.99%	563,709 $38.9 Million
Q1 2023 May 12, 2023	SELL	$43.42 - $57.37 $14.8 Million - $19.6 Million	-341,328 Reduced 85.81%	56,428 $2.72 Million
Q4 2022 Feb 10, 2023	BUY	$38.8 - $55.46 $448,605 - $641,228	11,562 Added 2.99%	397,756 $19.9 Million
Q3 2022 Nov 14, 2022	SELL	$38.15 - $57.1 $14.2 Million - $21.2 Million	-371,985 Reduced 49.06%	386,194 $15.8 Million
Q2 2022 Aug 12, 2022	BUY	$33.54 - $55.0 $25.4 Million - $41.7 Million	758,179 New	758,179 $41.7 Million

198

74.2M

374K

387K

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $8.12B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.